Clinical trial

Radiation Therapy and Cisplatin With or Without Amifostine for Patients With…

NCT00012012 · Radiation Therapy Oncology Group, Other · Completed

Key facts

NCT number NCT00012012
Title Radiation Therapy and Cisplatin With or Without Amifostine for Patients With Stage IIIB or IVA Cervical Cancer
Official title A Two Part Phase I/II Study Of Extended Field External Irradiation And Intracavitary Brachytherapy Combined With Chemotherapy And Amifostine In Carcinoma Of The Cervix With Positive Para-Aortic Or High Common Iliac Lymph Nodes
Lead sponsor Radiation Therapy Oncology Group, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Cervical Cancer, Radiation Toxicity
Intervention type Drug, Radiation
Interventions Amifostine trihydrate, Cisplatin, Intracavitary brachytherapy, External beam radiation therapy
Enrollment 45
Start date Aug 1, 2001
Primary completion Sep 1, 2007
Completion Jun 1, 2010
First posted Jan 27, 2003
Last update posted Jan 7, 2015
Countries United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies